(Q44482747)

English

Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy (English)

1 reference

Europe PubMed Central

3 December 2017

Helicobacter pylori

0 references

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Ping-I Hsu

1

1 reference

Europe PubMed Central

3 December 2017

Wen-Chi Chen

2

1 reference

Europe PubMed Central

3 December 2017

Feng-Woei Tsay

3

1 reference

Europe PubMed Central

3 December 2017

Chih-An Shih

4

1 reference

Europe PubMed Central

3 December 2017

Sung-Shuo Kao

5

1 reference

Europe PubMed Central

3 December 2017

Huay-Min Wang

6

1 reference

Europe PubMed Central

3 December 2017

Hsien-Chung Yu

7

1 reference

Europe PubMed Central

3 December 2017

Kwok-Hung Lai

8

1 reference

Europe PubMed Central

3 December 2017

Hui-Hwa Tseng

9

1 reference

Europe PubMed Central

3 December 2017

Nan-Jing Peng

10

1 reference

Europe PubMed Central

3 December 2017

Angela Chen

11

1 reference

Europe PubMed Central

3 December 2017

Chao-Hung Kuo

12

1 reference

Europe PubMed Central

3 December 2017

Deng-Chyang Wu

13

1 reference

Europe PubMed Central

3 December 2017

Taiwan Acid-Related Disease (TARD) Study Group

14

1 reference

Europe PubMed Central

3 December 2017

publication date

6 September 2013

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

19

1 reference

Europe PubMed Central

3 December 2017

1

1 reference

Europe PubMed Central

3 December 2017

74-79

1 reference

Europe PubMed Central

3 December 2017

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Optimal therapy for Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

A new look at anti-Helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12085

21 January 2018

Identifiers

10.1111/HEL.12085

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44482747&oldid=2025506647"